{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:03:39Z","timestamp":1781049819304,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Changsha City","award":["kq2208490"],"award-info":[{"award-number":["kq2208490"]}]},{"name":"the Natural Science Foundation of Hunan Provincial","award":["2023JJ30068"],"award-info":[{"award-number":["2023JJ30068"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04304-4","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:52:48Z","timestamp":1776354768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low NDFIP1-driven metabolic alterations in CD8\u2009+\u2009T cells: implications for immune evasion and therapy resistance in HNSC"],"prefix":"10.1186","volume":"26","author":[{"given":"Jun","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YiBo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YaFang","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"1","key":"4304_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson DE, et al. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"4304_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4304_CR3","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4304_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20(1):28.","journal-title":"Mol Cancer"},{"issue":"5","key":"4304_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5):325\u201337.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"4304_CR6","first-page":"667","volume":"61","author":"WX Zong","year":"2016","unstructured":"Zong WX, Rabinowitz JD, White E. Mitochondria Cancer Mol Cell. 2016;61(5):667\u201376.","journal-title":"Mitochondria Cancer Mol Cell"},{"issue":"6","key":"4304_CR7","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41590-021-00940-2","volume":"22","author":"Y Guo","year":"2021","unstructured":"Guo Y, et al. Metabolic reprogramming of terminally exhausted CD8(+) T cells by IL-10 enhances anti-tumor immunity. Nat Immunol. 2021;22(6):746\u201356.","journal-title":"Nat Immunol"},{"issue":"9","key":"4304_CR8","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41590-020-0725-2","volume":"21","author":"SA Vardhana","year":"2020","unstructured":"Vardhana SA, et al. Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen. Nat Immunol. 2020;21(9):1022\u201333.","journal-title":"Nat Immunol"},{"issue":"2","key":"4304_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3324\/haematol.2021.278530","volume":"107","author":"L Traeger","year":"2022","unstructured":"Traeger L, et al. UBA6 and NDFIP1 regulate the degradation of ferroportin. Haematologica. 2022;107(2):478\u201388.","journal-title":"Haematologica"},{"issue":"25","key":"4304_CR10","doi-asserted-by":"publisher","first-page":"11429","DOI":"10.1073\/pnas.0911714107","volume":"107","author":"T Mund","year":"2010","unstructured":"Mund T, Pelham HR. Regulation of PTEN\/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2. Proc Natl Acad Sci U S A. 2010;107(25):11429\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"D1","key":"4304_CR11","doi-asserted-by":"publisher","first-page":"D900","DOI":"10.1093\/nar\/gky939","volume":"47","author":"H Yuan","year":"2019","unstructured":"Yuan H, et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 2019;47(D1):D900\u20138.","journal-title":"Nucleic Acids Res"},{"key":"4304_CR12","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1038\/ncomms4887","volume":"5","author":"R Akbani","year":"2014","unstructured":"Akbani R, et al. A pan-cancer proteomic perspective on The Cancer Genome Atlas. Nat Commun. 2014;5:3887.","journal-title":"Nat Commun"},{"issue":"3","key":"4304_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2020.02.006","volume":"37","author":"H Liu","year":"2020","unstructured":"Liu H, et al. ADORA1 inhibition promotes tumor immune evasion by regulating the ATF3-PD-L1 Axis. Cancer Cell. 2020;37(3):324\u2013e3398.","journal-title":"Cancer Cell"},{"issue":"6","key":"4304_CR14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2019.05.004","volume":"35","author":"D Dangaj","year":"2019","unstructured":"Dangaj D, et al. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell. 2019;35(6):885\u2013e90010.","journal-title":"Cancer Cell"},{"issue":"6574","key":"4304_CR15","doi-asserted-by":"publisher","first-page":"abe6474","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng L, et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science. 2021;374(6574):abe6474.","journal-title":"Science"},{"issue":"6","key":"4304_CR16","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-023-02371-y","volume":"29","author":"Y Chu","year":"2023","unstructured":"Chu Y, et al. Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance. Nat Med. 2023;29(6):1550\u201362.","journal-title":"Nat Med"},{"issue":"2","key":"4304_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41591-019-0734-6","volume":"26","author":"BP Fairfax","year":"2020","unstructured":"Fairfax BP, et al. Peripheral CD8(+) T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma. Nat Med. 2020;26(2):193\u20139.","journal-title":"Nat Med"},{"issue":"5","key":"4304_CR18","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1172\/JCI73639","volume":"124","author":"A Gros","year":"2014","unstructured":"Gros A, et al. PD-1 identifies the patient-specific CD8(+) tumor-reactive repertoire infiltrating human tumors. J Clin Invest. 2014;124(5):2246\u201359.","journal-title":"J Clin Invest"},{"key":"4304_CR19","doi-asserted-by":"publisher","first-page":"1168306","DOI":"10.3389\/fendo.2023.1168306","volume":"14","author":"W Zhong","year":"2023","unstructured":"Zhong W, et al. The intricate mechanism of PLS3 in bone homeostasis and disease. Front Endocrinol (Lausanne). 2023;14:1168306.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"4304_CR20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41420-024-01944-1","volume":"10","author":"X Hua","year":"2024","unstructured":"Hua X, et al. MED15 is upregulated by HIF-2alpha and promotes proliferation and metastasis in clear cell renal cell carcinoma via activation of SREBP-dependent fatty acid synthesis. Cell Death Discov. 2024;10(1):188.","journal-title":"Cell Death Discov"},{"issue":"6481","key":"4304_CR21","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1126\/science.aaz5425","volume":"367","author":"Y Li","year":"2020","unstructured":"Li Y, et al. Structural insights into immunoglobulin M. Science. 2020;367(6481):1014\u20137.","journal-title":"Science"},{"issue":"6","key":"4304_CR22","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1021\/acscentsci.0c01592","volume":"7","author":"Y Fang","year":"2021","unstructured":"Fang Y, et al. Inhibiting Ferroptosis through Disrupting the NCOA4-FTH1 Interaction: A New Mechanism of Action. ACS Cent Sci. 2021;7(6):980\u20139.","journal-title":"ACS Cent Sci"},{"issue":"11","key":"4304_CR23","doi-asserted-by":"publisher","first-page":"5304","DOI":"10.4049\/jimmunol.1201445","volume":"189","author":"Y Wang","year":"2012","unstructured":"Wang Y, Tong X, Ye X. Ndfip1 negatively regulates RIG-I-dependent immune signaling by enhancing E3 ligase Smurf1-mediated MAVS degradation. J Immunol. 2012;189(11):5304\u201313.","journal-title":"J Immunol"},{"issue":"2","key":"4304_CR24","first-page":"123","volume":"14","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, et al. NDFIP1 limits cellular TAZ accumulation via exosomal sorting to inhibit NSCLC proliferation. Protein Cell. 2023;14(2):123\u201336.","journal-title":"Protein Cell"},{"issue":"2","key":"4304_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/jmcb\/mjv020","volume":"7","author":"J Howitt","year":"2015","unstructured":"Howitt J, et al. Ndfip1 represses cell proliferation by controlling Pten localization and signaling specificity. J Mol Cell Biol. 2015;7(2):119\u201331.","journal-title":"J Mol Cell Biol"},{"issue":"6","key":"4304_CR26","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s10534-013-9674-7","volume":"26","author":"H Xu","year":"2013","unstructured":"Xu H, et al. Iron status and lipopolysaccharide regulate Ndfip1 by activation of nuclear factor-kappa B. Biometals. 2013;26(6):981\u20138.","journal-title":"Biometals"},{"issue":"4","key":"4304_CR27","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, et al. The Immune Landscape of Cancer. Immunity. 2018;48(4):812\u2013e83014.","journal-title":"Immunity"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04304-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04304-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04304-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:53:26Z","timestamp":1781049206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04304-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4304"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04304-4","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"14 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of Changsha Hospital of Traditional Chinese Medicine approved the present study (Number: 2024110702). Written consents were obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"218"}}